← Portfolio Scout

Portfolio company

Synthekine

United States · £84.9m raised

Raised

£84.9m

Latest stage

Series B

Rounds recorded

1

Backed by

3 investors

Sectors

Digital Health

About

This company develops engineered cytokine therapeutics and protein engineering platforms for patients with cancer and autoimmune or inflammatory diseases.

Source

Funding history · 1

  1. 2021-06-10Series B$107.5m

Similar companies